Explore Cellular Landscapes Like Never Before
SITC ANNUAL MEETING • NOV 1–5 • SAN DIEGO, CA • BOOTH 313
We empower innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster.
Our proprietary technology ChipCytometry™ is a quantitative multiplex immunofluorescence imaging method for the spatial analysis of complex tissues and mapping of cell populations with single-cell resolution. Supported by Canopy Spatial Services™ with our CLIA-certified laboratory, we provide a unique collection of spatial and single-cell technologies that accelerate the understanding of cellular diversity and interaction.
See the data – check out the following posters:
Friday, Nov 3 from 9am-8:30pm in Exhibit Halls A and B1
Targeting FASN Sensitizes Irradiated Glioblastoma to Immune Checkpoint Blockade
Presenting Author: Mara De Martino, Ph.D., Postdoctoral Fellow, Claire Vanpouille-Box Laboratory, Weill Cornell Medicine
Abstract Number: 457
Saturday, Nov 4 from 9am-8:30pm in Exhibit Halls A and B1s
Switchable Antibodies for Increased Throughput in Iterative Immuno-Fluorescent Staining of Cancer Tissue Using ChipCytometry
Presenting Author: Thore Boettke, Ph.D., Canopy Biosciences
Abstract Number: 66
Investigating the Molecular Architecture of Triple Positive Breast Cancer Samples with Spatial Omics Technologies
Presenting Author: Kate Elston, Ph.D., Canopy Biosciences
Abstract Number: 1474
Featured Presentation
Saturday, Nov 4 at 12:10pm in Exhibit Hall D
Targeting FASN Sensitizes Irradiated Glioblastoma to Immune Checkpoint Blockade
Presenter: Mara De Martino, Ph.D., Postdoctoral Fellow, Claire Vanpouille-Box Laboratory, Weill Cornell Medicine
Session: Rapid Oral Abstract Session - Basic Science
Join Dr. De Martino's talk to learn how spatial multiplexing was used on the CellScape™ platform along with analysis performed in Enable Medicine to demonstrate the efficacy of targeting FASN along with irradiation in a glioblastoma model. Results unveiled discrete immune cell populations that may be responsible for the beneficial effects shown by the combined treatment.
